8 Breast Cancer Clinical Trials in New Brunswick, NJ (2026)

Q: How do I join a clinical trial in New Brunswick?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New Brunswick research site will contact you.

Recruiting Breast Cancer Studies in New Brunswick

NCT03424005Recruiting

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

This is an umbrella study evaluating the efficacy and safety of multiple treatment combinations in participants with metastatic or inoperable locally advanced breast cancer. The study will be perform...

New Brunswick, NJPHASE11,132 participantsHoffmann-La Roche

View Study Details

NCT06568692Recruiting

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

This is an adaptive Phase 2, open-label, randomized, multi-center study evaluating up to 2 regimens of PCS6422 with capecitabine (Cap) vs. standard dose of Cap alone in patients with advanced or metas...

New Brunswick, NJPHASE290 participantsProcessa Pharmaceuticals

View Study Details

NCT06686394Recruiting

Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

Researchers want to learn if patritumab deruxtecan (MK-1022) can treat certain breast cancers. The breast cancers being studied are HER2 positive unresectable locally advanced or metastatic (the cance...

New Brunswick, NJPHASE181 participantsMerck Sharp & Dohme LLC

View Study Details

NCT05559164Recruiting

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

This study proposes that the addition of statins reduces the treatment delays or early discontinuations secondary to cardiotoxicity in patients with Stage I-III HER2 positive breast being treated with...

New Brunswick, NJPHASE260 participantsRutgers, The State University of New Jersey

View Study Details

NCT07402473Recruiting

Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer

This is an open-label phase 2 study to evaluate the pCR rate in patients diagnosed with HER2 positive breast cancer treated on an adaptive clinical trial design. Tumors will undergo testing using a n...

New Brunswick, NJPHASE250 participantsRutgers, The State University of New Jersey

View Study Details

NCT06518837Recruiting

Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer

This clinical trial aims to evaluate the effectiveness of tirzepatide in achieving a 5% or more body weight reduction in patients undergoing adjuvant treatment for hormone receptor-positive, HER2-nega...

New Brunswick, NJPHASE240 participantsRutgers, The State University of New Jersey

View Study Details

NCT05736367Recruiting

Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer

To analyze the metabolic activity of Hormone Receptor Positive (HR+)/Her 2 Negative (Her2-) Breast cancer....

New Brunswick, NJNA16 participantsRutgers, The State University of New Jersey

View Study Details

NCT06139107Recruiting

RADIANT: Pre-op Radiation With Abemaciclib and Letrozole

This phase 1b study investigates the safety and feasibility of combining pre-operative radiation therapy with Cyclin-Dependent Kinase 4 (CDK4/6) inhibitors in participants with hormone receptor positi...

New Brunswick, NJPHASE115 participantsMridula George, MD

View Study Details

About Breast Cancer Clinical Trials in New Brunswick

Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.

There are currently 8 breast cancer clinical trials recruiting participants in New Brunswick, NJ. These studies are seeking a combined 1,484 participants. Research is being sponsored by Hoffmann-La Roche, Processa Pharmaceuticals, Merck Sharp & Dohme LLC and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Breast Cancer Clinical Trials in New Brunswick — FAQ

Are there breast cancer clinical trials in New Brunswick?

Yes, there are 8 breast cancer clinical trials currently recruiting in New Brunswick, NJ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Brunswick?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Brunswick research site will contact you about next steps.

Are clinical trials in New Brunswick free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Brunswick studies also compensate for your time and travel.

What breast cancer treatments are being tested?

The 8 active trials in New Brunswick are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.

Data updated July 19, 2026 from ClinicalTrials.gov